SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-314009
Filing Date
2019-12-13
Accepted
2019-12-13 17:00:03
Documents
9
Period of Report
2019-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d849185d8k.htm 8-K 32078
2 EX-4.1 d849185dex41.htm EX-4.1 134217
3 EX-10.1 d849185dex101.htm EX-10.1 21919
4 EX-10.2 d849185dex102.htm EX-10.2 158065
5 EX-10.3 d849185dex103.htm EX-10.3 8109
6 EX-10.4 d849185dex104.htm EX-10.4 46289
7 GRAPHIC g849185g1213115128130.jpg GRAPHIC 2148
8 GRAPHIC g849185page6.jpg GRAPHIC 7883
9 GRAPHIC g849185stamp_35.jpg GRAPHIC 3258
  Complete submission text file 0001193125-19-314009.txt   420679
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 191285169
SIC: 2835 In Vitro & In Vivo Diagnostic Substances